对肿瘤相关糖抗原进行小的结构修饰有可能发现新的抗肿瘤疫苗。由于硫苷具有对内源性糖苷酶的耐受性和非自身抗原特性,因此用S-连接的糖苷键代替O-连接的糖苷键对糖抗原进行修饰可能导致比天然的o-连接糖抗原更强的免疫原性,并可能刺激产生能够识别天然寡糖的抗体。为达此目的,我们成功完成了一个新的肿瘤相关二糖抗原STn的S-连接类似物的合成。
Modified tumor-associated carbohydrate antigens could be used to develop anti-cancer vaccines.Carbohydrate antigens in which thioglycosidic linkages are used instead of O-glycosidic linkages may be more immunogenic and may stimulate the production of antibodies capable of recognizing naturally occurring carbohydrates due to their enhanced resistance to endogenous glycosidases and their inherent non-self antigen character.For this purpose,a new S-linked tumor-associated carbohydrate antigen STn has been successfully synthesized for the first time.